Literature DB >> 34153156

Quantification of pharmaceuticals in the sealant fluids of actively used waterless urinals.

Utsav Thapa1, Priyamvada Sharma1, David Hanigan1.   

Abstract

Prior measurements at bench scale revealed that waterless urinal cartridges containing oily sealant fluids are capable of partitioning pharmaceuticals from urine and therefore reducing their concentration in wastewater. We sought to measure pharmaceutical removal from in-use waterless urinals. We developed a method to quantify pharmaceuticals in the sealant phase, which resulted in 79 ± 30% and 71 ± 30% recovery of eight pharmaceuticals from two sealant fluids, respectively. The method was applied to sealant samples collected over three weeks from in-use waterless urinals on a university campus. Six of eight pharmaceuticals were present in the sealant samples from 1.4 µg/L to 241 µg/L. Loads of the six pharmaceuticals detected in the sealants were removed from the receiving wastewater from 0.02 µg/day to 3.4 µg/day across the sampling period. The concentration of the pharmaceuticals were similar over time, indicating rapid saturation and washout of the sealant. We also observed relatively rapid loss of sealant at maintenance intervals consistent with the manufacturer's instructions. These findings indicate that while waterless urinals do remove some pharmaceuticals from the wastewater stream, meaningful changes to wastewater concentrations will only result if the sealant fluid and/or the urinal cartridge are significantly modified. PRACTITIONER POINTS: We developed a quantification method for pharmaceuticals in oily waterless urinal sealants. Pharmaceuticals were present at relatively low concentrations in the sealant phase of two in-use waterless urinals. We identify engineering challenges that must be overcome to meaningfully reduce pharmaceutical loads in wastewater with waterless urinals.
© 2021 Water Environment Federation.

Entities:  

Keywords:  PPCPs; TrOCs; emerging contaminants; partitioning; source separation; urine diversion; wastewater

Mesh:

Substances:

Year:  2021        PMID: 34153156      PMCID: PMC8863497          DOI: 10.1002/wer.1600

Source DB:  PubMed          Journal:  Water Environ Res        ISSN: 1061-4303            Impact factor:   1.946


  20 in total

1.  Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance.

Authors:  Dana W Kolpin; Edward T Furlong; Michael T Meyer; E Michael Thurman; Steven D Zaugg; Larry B Barber; Herbert T Buxton
Journal:  Environ Sci Technol       Date:  2002-03-15       Impact factor: 9.028

2.  Urine excretion of caffeine and select caffeine metabolites is common in the U.S. population and associated with caffeine intake.

Authors:  Michael E Rybak; Maya R Sternberg; Ching-I Pao; Namanjeet Ahluwalia; Christine M Pfeiffer
Journal:  J Nutr       Date:  2015-02-04       Impact factor: 4.798

3.  Tracking acidic pharmaceuticals, caffeine, and triclosan through the wastewater treatment process.

Authors:  Paul M Thomas; Gregory D Foster
Journal:  Environ Toxicol Chem       Date:  2005-01       Impact factor: 3.742

4.  Reducing micropollutants with source control: substance flow analysis of 212 pharmaceuticals in faeces and urine.

Authors:  J Lienert; T Bürki; B I Escher
Journal:  Water Sci Technol       Date:  2007       Impact factor: 1.915

5.  Multi-class multi-residue analysis of pesticides in edible oils by gas chromatography-tandem mass spectrometry using liquid-liquid extraction and enhanced matrix removal lipid cartridge cleanup.

Authors:  Limian Zhao; Thomas Szakas; Melissa Churley; Derick Lucas
Journal:  J Chromatogr A       Date:  2018-12-06       Impact factor: 4.759

6.  Pharmaceutical occurrence in groundwater and surface waters in forests land-applied with municipal wastewater.

Authors:  Andrew D McEachran; Damian Shea; Wanda Bodnar; Elizabeth Guthrie Nichols
Journal:  Environ Toxicol Chem       Date:  2015-12-09       Impact factor: 3.742

7.  Reducing the discharge of micropollutants in the aquatic environment: the benefits of upgrading wastewater treatment plants.

Authors:  Rik I L Eggen; Juliane Hollender; Adriano Joss; Michael Schärer; Christian Stamm
Journal:  Environ Sci Technol       Date:  2014-06-19       Impact factor: 9.028

8.  Pharmacokinetic profile of trimethoprim-sulfamethoxazole in man.

Authors:  S A Kaplan; R E Weinfeld; C W Abruzzo; K McFaden; M L Jack; L Weissman
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

Review 9.  Trimethoprim-sulfamethoxazole revisited.

Authors:  Philip A Masters; Thomas A O'Bryan; John Zurlo; Debra Q Miller; Nirmal Joshi
Journal:  Arch Intern Med       Date:  2003-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.